Downregulation of miR-151-5p Contributes to Increased Susceptibility to Arrhythmogenesis during Myocardial Infarction with Estrogen Deprivation

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Zhang, Ying ^a   Wang, Renjun ^a   Du, Weijie ^a   Wang, Shuxuan ^a   Yang, Lei ^b   Pan, Zhenwei ^a   Li, Xuelian ^a   Xiong, Xuehui ^a   He, Hua ^a   Shi, Yongfang ^a   Liu, Xue ^a   Yu, Shaonan ^a   Bi, Zhengang ^b   Lu, Yanjie ^a   Shan, Hongli ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CALCIUM ION; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; MICRORNA; MICRORNA 151 5P; PEPTIDES AND PROTEINS; PHOSPHOLEMMAN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; CHEMICAL BINDING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DOWN REGULATION; ESTROGEN DEFICIENCY; FEMALE; FXYD1 GENE; GENE; GENE EXPRESSION REGULATION; HEART ELECTROPHYSIOLOGY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; MEMBRANE STEADY POTENTIAL; MOLECULAR PATHOLOGY; MORTALITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; UPREGULATION;

ACTION POTENTIALS; ANIMALS; ANIMALS, NEWBORN; ARRHYTHMIAS, CARDIAC; CALCIUM; CELL LINE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HEART VENTRICLES; HUMANS; INTRACELLULAR SPACE; MICRORNAS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PROTEIN BINDING; PROTEIN TRANSPORT; RATS;

EID: 84883616123     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072985     Document Type: Article

References (44)

1. Eaker ED, Chesebro JH, Sacks FM, Wenger NK, Whisnant JP, et al. (1993) Cardiovascular disease in women. Circulation 88: 1999-2009.
2. Lerner DJ, Kannel WB, (1986) Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 111: 383-390.
3. Stampfer MJ, Colditz GA, (1991) Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 20: 47-63.
4. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, et al. (1992) Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117: 1016-1037.
5. Sidney S, Petitti DB, Quesenberry CP Jr, (1997) Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women. Ann Intern Med 127: 501-508.
6. Mikkola TS, Clarkson TB, (2002) Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res 53: 605-619.
7. Esteller M, (2011) Non-coding RNAs in human disease. Nat Rev Genet 12: 861-874.
8. Xie X, Lu J, Kulbokas EJ, Golub TR, Mootha V, et al. (2005) Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature 434: 338-345.
9. Jackson RJ, Standart N, (2007) How do microRNAs regulate gene expression? Sci STKE 2007: re1.
10. Yang B, Lin H, Xu C, Liu Y, Wang H, et al. (2005) Choline produces cytoprotective effects against ischemic myocardial injuries: evidence for the role of cardiac m3 subtype muscarinic acetylcholine receptors. Cell Physiol Biochem 16: 163-174.
11. Curtis MJ, Walker MJ, (1988) Quantification of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia. Cardiovasc Res 22: 656-665.
12. Shan H, Li X, Pan Z, Zhang L, Cai B, et al. (2009) Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1. Br J Pharmacol 158: 1227-1235.
13. Li X, Chu W, Liu J, Xue X, Lu Y, et al. (2009) Antiarrhythmic properties of long-term treatment with matrine in arrhythmic rat induced by coronary ligation. Biol Pharm Bull 32: 1521-1526.
14. Yang BF, Luo DL, Bao LH, Zhang YC, Wang HZ, (1998) Artemisinin blocks activating and slowly activating K+ current in guinea pig ventricular myocytes. Zhongguo Yao Li Xue Bao 19: 269-272.
15. Dong DL, Liu Y, Zhou YH, Song WH, Wang H, et al. (2004) Decreases of voltage-dependent K+ currents densities in ventricular myocytes of guinea pigs by chronic oxidant stress. Acta Pharmacol Sin 25: 751-755.
16. Zhang Y, Liu Y, Wang T, Li B, Li H, et al. (2006) Resveratrol, a natural ingredient of grape skin: antiarrhythmic efficacy and ionic mechanisms. Biochem Biophys Res Commun 340: 1192-1199.
17. Dong DL, Chen C, Huo R, Wang N, Li Z, et al. (2010) Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy. Hypertension 55: 946-952.
18. Yang B, Lin H, Xiao J, Lu Y, Luo X, et al. (2007) The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 13: 486-491.
19. Luo X, Xiao J, Lin H, Li B, Lu Y, et al. (2007) Transcriptional activation by stimulating protein 1 and post-transcriptional repression by muscle-specific microRNAs of IKs-encoding genes and potential implications in regional heterogeneity of their expressions. J Cell Physiol 212: 358-367.
20. Wang H, Zhang Y, Cao L, Han H, Wang J, et al. (2002) HERG K+ channel, a regulator of tumor cell apoptosis and proliferation. Cancer Res 62: 4843-4848.
21. Pang L, Koren G, Wang Z, Nattel S, (2003) Tissue-specific expression of two human Ca(v)1.2 isoforms under the control of distinct 5′ flanking regulatory elements. FEBS Lett 546: 349-354.
22. Chu WF, Sun HL, Dong DL, Qiao GF, Yang BF, (2006) Increasing Intracellular calcium of guinea pig ventricular myocytes induced by platelet activating factor through IP3 pathway. Basic Clin Pharmacol Toxicol 98: 104-109.
23. Backes C, Meese E, Lenhof HP, Keller A, (2010) A dictionary on microRNAs and their putative target pathways. Nucleic Acids Res 38: 4476-4486.
24. Chen T, Mally A, Ozden S, Chipman JK, (2010) Low doses of the carcinogen furan alter cell cycle and apoptosis gene expression in rat liver independent of DNA methylation. Environ Health Perspect 118: 1597-1602.
25. Presti CF, Jones LR, Lindemann JP, (1985) Isoproterenol-induced phosphorylation of a 15-kilodalton sarcolemmal protein in intact myocardium. J Biol Chem 260: 3860-3867.
26. Lindemann JP, (1986) Alpha-adrenergic stimulation of sarcolemmal protein phosphorylation and slow responses in intact myocardium. J Biol Chem 261: 4860-4867.
27. Presti CF, Scott BT, Jones LR, (1985) Identification of an endogenous protein kinase C activity and its intrinsic 15-kilodalton substrate in purified canine cardiac sarcolemmal vesicles. J Biol Chem 260: 13879-13889.
28. Shattock MJ, (2009) Phospholemman: its role in normal cardiac physiology and potential as a druggable target in disease. Curr Opin Pharmacol 9: 160-166.
29. Dong S, Cheng Y, Yang J, Li J, Liu X, et al. (2009) MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem 284: 29514-29525.
30. Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, et al. (2007) Altered microRNA expression in human heart disease. Physiol Genomics 31: 367-373.
31. van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, et al. (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 105: 13027-13032.
32. Yin C, Wang X, Kukreja RC, (2008) Endogenous microRNAs induced by heat-shock reduce myocardial infarction following ischemia-reperfusion in mice. FEBS Lett 582: 4137-4142.
33. Crambert G, Fuzesi M, Garty H, Karlish S, Geering K, (2002) Phospholemman (FXYD1) associates with Na,K-ATPase and regulates its transport properties. Proc Natl Acad Sci U S A 99: 11476-11481.
34. Zhang XQ, Qureshi A, Song J, Carl LL, Tian Q, et al. (2003) Phospholemman modulates Na+/Ca2+ exchange in adult rat cardiac myocytes. Am J Physiol Heart Circ Physiol 284: H225-233.
35. Mirza MA, Zhang XQ, Ahlers BA, Qureshi A, Carl LL, et al. (2004) Effects of phospholemman downregulation on contractility and [Ca(2+)]i transients in adult rat cardiac myocytes. Am J Physiol Heart Circ Physiol 286: H1322-1330.
36. Ahlers BA, Zhang XQ, Moorman JR, Rothblum LI, Carl LL, et al. (2005) Identification of an endogenous inhibitor of the cardiac Na+/Ca2+ exchanger, phospholemman. J Biol Chem 280: 19875-19882.
37. Wang X, Gao G, Guo K, Yarotskyy V, Huang C, et al. (2010) Phospholemman modulates the gating of cardiac L-type calcium channels. Biophys J 98: 1149-1159.
38. Bossuyt J, Despa S, Han F, Hou Z, Robia SL, et al. (2009) Isoform specificity of the Na/K-ATPase association and regulation by phospholemman. J Biol Chem 284: 26749-26757.
39. Despa S, Bossuyt J, Han F, Ginsburg KS, Jia LG, et al. (2005) Phospholemman-phosphorylation mediates the beta-adrenergic effects on Na/K pump function in cardiac myocytes. Circ Res 97: 252-259.
40. Song J, Zhang XQ, Carl LL, Qureshi A, Rothblum LI, et al. (2002) Overexpression of phospholemman alters contractility and [Ca(2+)](i) transients in adult rat myocytes. Am J Physiol Heart Circ Physiol 283: H576-583.
41. Song J, Zhang XQ, Ahlers BA, Carl LL, Wang J, et al. (2005) Serine 68 of phospholemman is critical in modulation of contractility, [Ca2+]i transients, and Na+/Ca2+ exchange in adult rat cardiac myocytes. Am J Physiol Heart Circ Physiol 288: H2342-2354.
42. Sehl PD, Tai JT, Hillan KJ, Brown LA, Goddard A, et al. (2000) Application of cDNA microarrays in determining molecular phenotype in cardiac growth, development, and response to injury. Circulation 101: 1990-1999.
43. Zhang XQ, Moorman JR, Ahlers BA, Carl LL, Lake DE, et al. (2006) Phospholemman overexpression inhibits Na+-K+-ATPase in adult rat cardiac myocytes: relevance to decreased Na+ pump activity in postinfarction myocytes. J Appl Physiol 100: 212-220.
44. Ding J, Huang S, Wu S, Zhao Y, Liang L, et al. (2010) Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat Cell Biol 12: 390-399.